Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|January 12, 2020
Magnitude and Functional Profile of the Human CD4<sup>+</sup> T Cell Response throughout Primary Immunization with Tick-Borne Encephalitis Virus VaccineRenata Varnaitė, Kim Blom, Margit H Lampen, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 13, 2017
Investigation of a food-borne outbreak of gastroenteritis in a school canteen revealed a variant of sapovirus genogroup V not detected by standard PCR, Sollentuna, Sweden, 2016Maria-Pia Hergens, Joanna Nederby Öhd, Erik Alm, et al.
The Journal of Infectious Diseases|September 24, 2024
Clinical Characteristics of Tick-Borne Encephalitis in Adult Patients: A 10-year Retrospective Study in Stockholm, SwedenSofia Bartholdsson, Maria-Pia Hergens, Karin E Hansson, et al.
Emerging Infectious Diseases|November 7, 2009
Serologic analysis of returned travelers with fever, SwedenHelena H Askling, Birgitta Lesko, Sirkka Vene, et al.
Malaria Journal|September 19, 2012
Management of imported malaria in EuropeHelena H Askling, Fabrice Bruneel, Gerd Burchard, et al.
Vaccine|November 13, 2024
Safety and immunogenicity of the Ad26/protein preF RSV vaccine in adults aged 18 to 59 years with and without at-risk comorbidities for severe respiratory syncytial virus disease: A phase 3, randomized, controlled, immunobridging trialArchana Jastorff, Efi Gymnopoulou, Jose Salas, et al.
Travel Medicine and Infectious Disease|March 18, 2018
Safety and immunogenicity of an inactivated Vero cell_derived Japanese encephalitis vaccine (IXIARO<sup>®</sup>, JESPECT<sup>®</sup>) in a pediatric population in JE non-endemic countries: An uncontrolled, open-label phase 3 studyTomas Jelinek, Michael A Cromer, Jakob P Cramer, et al.
JMIR Public Health and Surveillance|April 4, 2024
Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey StudySophia Themistocleous, Christos D Argyropoulos, Paris Vogazianos, et al.
Vaccine|May 20, 2023
VACCELERATE Site Network: Real-time definition of clinical study capacity in EuropeJon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, et al.
Vaccines|December 23, 2023
The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE ConsortiumDimitrios Poulimeneas, Markela Koniordou, Dimitra Kousi, et al.
Pageof 3